心臓 不全 で 急死 の 危険 が 減少 する:事実 か,神話 か
PubMedで要約を見る
まとめ
この要約は機械生成です。心不全患者の急性心臓死 (SCD) のリスクは,広く信じられているように減少していないかもしれません. このレビューは,SCDの減少を疑問視し,HFの管理にインプラント可能なカーディオバーター除細動器の継続的な使用を提唱しています.
科学分野
- 心臓病科
- 心不全 の 研究
- 突然 の 心臓 発作 死 の 研究
背景
- ガイドライン指向医療療法 (GDMT) を受けている心不全患者では,突然心臓死 (SCD) のリスクが低下しているとの認識が強まっている.
- エディトリアルでは,不律性SCDはもはやGDMTを受けるHF患者にとって重大な脅威ではないことを示唆しています.
研究 の 目的
- HF試験と実際の環境でSCDのリスクが本当に減少したかどうかを批判的に評価する.
- GDMTにもかかわらず,残留 SCD リスクがインプラント可能な心筋動器 (ICD) の継続的使用を正当化するかどうかを評価する.
- HF試験の結果を臨床実用化する方法を検討する.
主な方法
- 心不全の臨床試験から得られた既存のデータのレビュー
- SCDの発生率に関する現実世界の証拠の分析
- HFにおけるGDMTとデバイス療法に関する研究の批判的評価
主要な成果
- 証拠によると,SCDはHF試験や実際の集団では減少していない.
- ガイドライン指向型デバイス療法 (GDDT) に従わない試験のデータは,ICDの移植を遅らせるのに不十分である.
- HF試験の結果を様々な現実の患者集団に適用する際には課題があります.
結論
- HF患者におけるSCDリスクの減少は不正確である可能性があります.
- ICD治療は慢性HFにおける残留SCDリスクの管理に不可欠です.
- 将来のHF試験は,ICDの役割をより明確にするためにGDDTを組み込むべきです.
関連する概念動画
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...

